Is plasma homocysteine level associated with metabolic syndrome components in adolescents?

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 4, 2009, Pages 357-361

  Budak, Nurten ^a   Yazici, Cevad ^a   Öztürk, Ahmet ^a   Bayram, Fahri ^a   Mazicioǧlu, M Mümtaz ^a   Kurtoglu, Selim ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BLOOD PRESSURE; CHILD; CHOLESTEROL, HDL; FEMALE; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; RISK FACTORS; TURKEY;

EID: 68549106035     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2008.0037     Document Type: Article

References (32)

1. International Diabetes Federation (IDF). The IDF consensus worldwide definition of the METABOLIC SYNDROME. Belgium: IDF Communications; 2006.
2. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willet WC, Stampfer MJA. Prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 1994;25:1924-1930. (Pubitemid 24291274)
3. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jacobs C, Boute LM, Heine RJ, Stehouver CD. Hyperhomocysteinaemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus:a population- based study. Arterioscler Thromb Vasc Biol 1998;18:133-138.
4. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort. Stroke 2004;35:2263-2270.
5. Garcin JM, Mayaudon H, Bauduceau B, Abouzahir A, Burnat P, Gardet V, Bordier L, Dupuy O, Baigts F. Is mild hyperhomocysteinemia an additional risk factor of the metabolic syndrome? Rev Med Intern 2005, 26:695-702. (Pubitemid 41261979)
6. Oron-Herman M, Rosenthal T, Sela BA. Hyperhomo cysteinemia as a component of syndrome X. Metabolism 2003;52:1491-1495.
7. Hajer GR, Van der Graaf Y, Olijhoek JK, Verhaar MC, Vissseren FL. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 2007;93:216-220. (Pubitemid 46180299)
8. Guven A, Inanc F, Kilinc M, Ekerbicer H. Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome. Heart Ves 2005;20:290-295. (Pubitemid 43013220)
9. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic syndrome in Turkish children and adolescents. Metabolism Clin Exper 2006;55:1002-1006. (Pubitemid 44040981)
10. Grundy SM, Cleemen JI, Daniels RS, Donate KA, Eckel RH, Franklin BA, Gordon DC, Krauss RM, Savage PJ, Smith Jr SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome. Circulation 2005;112:2735-2752.
11. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239. (Pubitemid 38924592)
12. McCarthy HD, Jarrett KV, Crawly HF. The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J Clin Nutr 2001;55:902-907.
13. Atabek ME, Pirgon Ö, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 2006;72:315-321. (Pubitemid 44250897)
14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The Fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555-576.
15. Tümer N, Yalçinkaya F, İnce E et al. Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 1999;13:438-443. (Pubitemid 29276742)
16. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-e503.
17. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight an obesity worldwide:international survey. Br Med J 2000;320:1240-1243. (Pubitemid 30240471)
18. Godsland JF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001;86:719-723.
19. Bjorck J, Hellgren M, Rastam L, Lindblad U. Association between serum insulin and homocysteine in a Swedish population- a potential link between the metabolic syndrome and hyperhomocysteinemia: The Skaraborg project. Metabolism 2006;55: 1007-1013.
20. Jermendy G, Hidvege T, Hetyesi K. Plasma homocysteine levels in hyperinsulinemic patients. Orv Hetil 2001;11:277-281.
21. Meigs JB, Jaques PF, Selhub J, Singer DE, Nathan DM, Rifai N. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diab Care 2001;24:1403-1410.
22. Selhub J. Homocysteine metabolism. Ann Rev Nutr 1999;19:217-246.
23. Kulkarni K, Richard BC. Lifestyle, homocysteine, and the metabolic syndrome. Metabol Syndr Rel Disord 2003;1:141-147.
24. Brasileiro RS, Escrivao MA, Taddei JA, D'Almedia V, Ancona- Lopez F, Carvalhaes JT. Plasma total homocysteine in Brazilian overweight and non-overweight adolescents: A case-control study. Nutr Hosp 2005;20:313-319.
25. Onat A, Hergenç G, Küçükdurmaz Z, Can G, Ayhan E, Bulur S. Serum folate is associated with independently homocysteine in Turkish men. Clin Nutr 2008; (in press).
26. Bar-On H, Kidron M, Friedlander Y, Ben-Yehuda A, Selhub J, Rosenberg IH, Fridman G. Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med 2000;247:287-294. (Pubitemid 30108364)
27. Das UN. Is Metabolic syndrome X an inflammatory condition? Exp Bio Med 2002:227:989-997.
28. Sentí M,Tomás M, Fitó M, Weinbrenner T, Covas MI, Sala J, Masiá R, Marrugat J. Antioxidant paraoxonase 1 activity in the MetS. J Clin Endocrinol Metab 2003;88:5422-5426.
29. Mackness MI, Arrol S, Abbott CA, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993;104:129-135. (Pubitemid 24035640)
30. Aviram M, Rosenblat M, Bisgaier CL. Paraoxonase inhibits high density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-1590. (Pubitemid 28198486)
31. Garin M-CB, Kalix B, Morabia A, James RW. Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the Metabolic Syndrome. J Clin Invest 2005;90:2264-2269. (Pubitemid 40586272)
32. Meuwese MC, Stroes, ES, Hazen SL, van Miert JN, Kuivenhoven JA, Schaub RG, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;50:159-165. (Pubitemid 47002189)